These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7971476)

  • 21. Haemodialysis activates phospholipase A2 enzyme.
    Vishwanath BS; Fux CA; Uehlinger DE; Frey BM; Franson RC; Frey FJ
    Nephrol Dial Transplant; 1996 Jan; 11(1):109-16. PubMed ID: 8649616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biocompatible dialysis membranes and acute renal failure: a study in post-operative acute tubular necrosis in cadaveric renal transplant recipients.
    Valeri A; Radhakrishnan J; Ryan R; Powell D
    Clin Nephrol; 1996 Dec; 46(6):402-9. PubMed ID: 8982557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of platelets and hemostasis during hemodialysis with six different membranes.
    Verbeelen D; Jochmans K; Herman AG; Van der Niepen P; Sennesael J; De Waele M
    Nephron; 1991; 59(4):567-72. PubMed ID: 1766495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum beta 2-microglobulin levels in patients chronically dialyzed with CA-210 versus CT-190 dialysis membranes.
    DeFranco P; Farrell J; Gellens M; Bastani B
    Am J Nephrol; 1998; 18(1):16-20. PubMed ID: 9481434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of dialyzer geometry during hemodialysis with cuprophane membranes.
    Taylor JE; McLaren M; Mactier RA; Henderson IS; Stewart WK; Belch JJ
    Kidney Int; 1992 Aug; 42(2):442-7. PubMed ID: 1405328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Does the biocompatibility of the hemodialysis membrane influence the prognosis of acute renal insufficiency?].
    Tielemans C; Gastaldello K; Melot C; Kahn RJ; Vanherweghem JL
    Nephrologie; 1998; 19(2):89-91. PubMed ID: 9592779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodialysis-associated platelet activation and thrombocytopenia.
    Hakim RM; Schafer AI
    Am J Med; 1985 Apr; 78(4):575-80. PubMed ID: 3885730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid activation of the complement system by cuprophane depends on complement component C4.
    Lhotta K; Würzner R; Kronenberg F; Oppermann M; König P
    Kidney Int; 1998 Apr; 53(4):1044-51. PubMed ID: 9551416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the mechanisms of haemodialysis-induced neutropenia: a study with five new and re-used membranes.
    Heierli C; Markert M; Lambert PH; Kuwahara T; Wauters JP
    Nephrol Dial Transplant; 1988; 3(6):773-83. PubMed ID: 3147419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of blood compatibility on cellulose dialysis membrane. 2. Blood compatibility of phospholipid polymer grafted cellulose membrane.
    Ishihara K; Takayama R; Nakabayashi N; Fukumoto K; Aoki J
    Biomaterials; 1992; 13(4):235-9. PubMed ID: 1520829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of different dialyzer membranes on serum angiotensin-converting enzyme during hemodialysis.
    Docci D; Delvecchio C; Turci F; Baldrati L; Gollini C
    Int J Artif Organs; 1988 Jan; 11(1):28-32. PubMed ID: 2834297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of modern microscopic techniques for examining dialysis membrane properties].
    Kowal A; Nowak S; Sułowicz W; Pietrzyk JA; Krawentek L; Drozdz M; Nowogrodzka-Zagórska M; Bal W
    Przegl Lek; 2000; 57(12):702-6. PubMed ID: 11398590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellulose acetate and cuprophane for hemodialysis: effects on protein catabolic rate.
    Robles NR; Gomez-Ainsua C; Cruz A
    Nephron; 1995; 70(4):508-9. PubMed ID: 7477664
    [No Abstract]   [Full Text] [Related]  

  • 34. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodialysis with cuprophane membrane modulates interleukin-2 receptor expression.
    Zaoui P; Green W; Hakim RM
    Kidney Int; 1991 May; 39(5):1020-6. PubMed ID: 2067197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biocompatibility and hemodynamic studies during polycarbonate versus cuprophane membrane dialysis.
    Schohn DC; Jahn HA; Eber M; Hauptmann G
    Blood Purif; 1986; 4(1-3):102-11. PubMed ID: 3730154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limulus amebocyte lysate reactivity, complement activation, and patients' symptoms. Comparison of dialyzer membranes.
    Moss AH; Hamrick RM; Shen SH
    ASAIO Trans; 1989; 35(4):812-5. PubMed ID: 2611049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [C-reactive protein (CRP) as a marker of of hemodialysis biocompatibility].
    Szepietowski T; Krajewska M
    Polim Med; 1997; 27(1-2):47-59. PubMed ID: 9380601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiolucent bone cysts and the type of dialysis membrane used in patients undergoing long-term hemodialysis.
    Miura Y; Ishiyama T; Inomata A; Takeda T; Senma S; Okuyama K; Suzuki Y
    Nephron; 1992; 60(3):268-73. PubMed ID: 1565178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.